Cyclerion Therapeutics Inc (CYCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 133 | 400 | 749 | 1,014 | 1,481 |
| Gross Profit | 133 | 400 | 749 | 1,014 | 1,481 |
| Operating Expenses | 19,357 | 22,180 | 20,421 | 21,603 | 28,067 |
| Operating Income | -19,224 | -21,780 | -19,672 | -20,589 | -26,586 |
| Other Income | -4 | 2,968 | 138 | 361 | 530 |
| Pre-tax Income | -19,228 | -18,812 | -19,534 | -20,228 | -26,056 |
| Net Income Continuous | -19,228 | -18,812 | -19,534 | -20,228 | -26,056 |
| Net Income | $-19,228 | $-18,812 | $-19,534 | $-20,228 | $-26,056 |
| EPS Basic Total Ops | -10.80 | -11.80 | -14.00 | -14.60 | -18.80 |
| EPS Basic Continuous Ops | -10.78 | -11.72 | -14.06 | -14.62 | -19.08 |
| EPS Diluted Total Ops | -10.80 | -11.80 | -14.00 | -14.60 | -18.80 |
| EPS Diluted Continuous Ops | -10.78 | -11.72 | -14.06 | -14.62 | -19.08 |
| EBITDA(a) | $-18,754 | $-21,192 | $-19,059 | $-19,963 | $-25,933 |